Literature DB >> 33458832

World-wide tracking of major SARS-CoV-2 genome haplotypes in sequences of June 1 to November 15, 2020 and discovery of rapid expansion of a new haplotype.

Iman Safari1, Kolsoum InanlooRahatloo1, Elahe Elahi1.   

Abstract

Earlier, 13 haplotype groups defined by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome sequence variations were identified in 2790 sequences available in March 2020. Also, 23403A>G that causes p. Asp614Gly in the spike protein and is one of the defining variations of the haplotype group H1, was becoming increasingly prevalent. As a follow-up, 74922 SARS-CoV-2 sequences retrieved from individuals infected in June 1 to November 15 were analyzed. Consistent with the reports on 23403A>G, H1 haplotype frequency increased world-wide; among August to November sequences, only 0.3% were associated with non-H1 haplotypes. This finding prompted assessment of H1 sub-haplotypes among the sequences of the later stage of the coronavirus disease 2019 pandemic. The distribution of the sub-haplotypes differed in different regions, but 98.4% of the sequences were associated with five H1 sub-haplotypes. One of these had not been previously observed and had emerged in Europe by June 2020. The most important finding of the present study is identification of this new sub-haplotype (H1r) and finding evidence that suggest it may have a high potential for expansion. Its frequency had reached 10%-90% in various countries/territories of Europe by the end of September. The new sub-haplotype is defined by seven sequence variations, one of which causes Ala222Val in the spike protein.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  SARS-CoV-2; new haplotype; nucleotide variations; prevalent haplotypes

Mesh:

Substances:

Year:  2021        PMID: 33458832     DOI: 10.1002/jmv.26802

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

Review 1.  Evolution of the SARS-CoV-2 genome and emergence of variants of concern.

Authors:  Iman Safari; Elahe Elahi
Journal:  Arch Virol       Date:  2021-11-30       Impact factor: 2.685

2.  SARS-CoV-2 in Egypt: epidemiology, clinical characterization and bioinformatics analysis.

Authors:  Badriyah Alotaibi; Thanaa A El-Masry; Mohamed G Seadawy; Mahmoud H Farghali; Bassem E El-Harty; Asmaa Saleh; Yasmen F Mahran; Jackline S Fahim; Mohamed S Desoky; Mohamed M E Abd El-Monsef; Maisra M El-Bouseary
Journal:  Heliyon       Date:  2022-01-31

3.  Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.

Authors:  Peyman Taghizadeh; Sadegh Salehi; Ali Heshmati; Seyed Massoud Houshmand; Kolsoum InanlooRahatloo; Forouzandeh Mahjoubi; Mohammad Hossein Sanati; Hadi Yari; Afagh Alavi; Saeid Amel Jamehdar; Soroosh Dabiri; Hamid Galehdari; Mohammad Reza Haghshenas; Amir Masoud Hashemian; Abtin Heidarzadeh; Issa Jahanzad; Elham Kheyrani; Ahmad Piroozmand; Ali Mojtahedi; Hadi Razavi Nikoo; Mohammad Masoud Rahimi Bidgoli; Nayebali Rezvani; Mehdi Sepehrnejad; Arash Shakibzadeh; Gholamreza Shariati; Noorossadat Seyyedi; Seyed MohammadSaleh Zahraei; Iman Safari; Elahe Elahi
Journal:  Virology       Date:  2021-06-19       Impact factor: 3.513

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.